507 related articles for article (PubMed ID: 17238219)
1. How important is consent in maternal serum screening for Down syndrome in France? Information and consent evaluation in maternal serum screening for Down syndrome: a French study.
Favre R; Duchange N; Vayssière C; Kohler M; Bouffard N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Moutel G
Prenat Diagn; 2007 Mar; 27(3):197-205. PubMed ID: 17238219
[TBL] [Abstract][Full Text] [Related]
2. What about informed consent in first-trimester ultrasound screening for Down syndrome?
Favre R; Moutel G; Duchange N; Vayssière C; Kohler M; Bouffet N; Hunsinger MC; Kohler A; Mager C; Neumann M; Vayssière C; Viville B; Hervé C; Nisand I
Fetal Diagn Ther; 2008; 23(3):173-84. PubMed ID: 18417975
[TBL] [Abstract][Full Text] [Related]
3. Pregnant women's attitudes toward amniocentesis before receiving Down syndrome screening results.
Brajenović-Milić B; Babić I; Ristić S; Vraneković J; Brumini G; Kapović M
Womens Health Issues; 2008; 18(2):79-84. PubMed ID: 18180167
[TBL] [Abstract][Full Text] [Related]
4. Informed choice in women attending private clinics to undergo first-trimester screening for Down syndrome.
Jaques AM; Sheffield LJ; Halliday JL
Prenat Diagn; 2005 Aug; 25(8):656-64. PubMed ID: 16049990
[TBL] [Abstract][Full Text] [Related]
5. [Prenatal screening for trisomy 21 with maternal serum markers: information for decision-making in pregnant women].
Seror V; Costet N; Ayme S
J Gynecol Obstet Biol Reprod (Paris); 2000 Sep; 29(5):492-500. PubMed ID: 11011279
[TBL] [Abstract][Full Text] [Related]
6. Informed consent for antenatal serum screening for Down syndrome.
Hwa HL; Huang LH; Hsieh FJ; Chow SN
Taiwan J Obstet Gynecol; 2010 Mar; 49(1):50-6. PubMed ID: 20466293
[TBL] [Abstract][Full Text] [Related]
7. First-trimester Down syndrome screening: pregnant women's knowledge.
Dahl K; Hvidman L; Jørgensen FS; Henriques C; Olesen F; Kjaergaard H; Kesmodel US
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):145-51. PubMed ID: 20878670
[TBL] [Abstract][Full Text] [Related]
8. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
Gourounti K; Sandall J
Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
[TBL] [Abstract][Full Text] [Related]
9. A survey of the knowledge and attitudes of pregnant Thai women towards Down syndrome screening.
Pruksanusak N; Suwanrath C; Kor-Anantakul O; Prasartwanakit V; Leetanaporn R; Suntharasaj T; Hanprasertpong T
J Obstet Gynaecol Res; 2009 Oct; 35(5):876-81. PubMed ID: 20149035
[TBL] [Abstract][Full Text] [Related]
10. The evolving national birth prevalence of Down syndrome in Taiwan. A study on the impact of second-trimester maternal serum screening.
Jou HJ; Kuo YS; Hsu JJ; Shyu MK; Hsieh TT; Hsieh FJ
Prenat Diagn; 2005 Aug; 25(8):665-70. PubMed ID: 16049991
[TBL] [Abstract][Full Text] [Related]
11. [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
Christiansen M; Petersen PL; Permin M; Larsen LA; Nørgaard-Pedersen B
Ugeskr Laeger; 1999 Dec; 161(50):6928-34. PubMed ID: 10643380
[TBL] [Abstract][Full Text] [Related]
12. Written patient information about triple-marker screening: a randomized, controlled trial.
Glazier R; Goel V; Holzapfel S; Summers A; Pugh P; Yeung M
Obstet Gynecol; 1997 Nov; 90(5):769-74. PubMed ID: 9351762
[TBL] [Abstract][Full Text] [Related]
13. Knowledge of prenatal screening and psychological management of test decisions.
Dahl K; Hvidman L; Jørgensen FS; Kesmodel US
Ultrasound Obstet Gynecol; 2011 Aug; 38(2):152-7. PubMed ID: 20954167
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the decision-making process regarding amniocentesis following a screen-positive maternal serum screen result.
Kobelka C; Mattman A; Langlois S
Prenat Diagn; 2009 May; 29(5):514-9. PubMed ID: 19242922
[TBL] [Abstract][Full Text] [Related]
15. Evaluating patient's knowledge of maternal serum screening.
Goel V; Glazier R; Holzapfel S; Pugh P; Summers A
Prenat Diagn; 1996 May; 16(5):425-30. PubMed ID: 8844000
[TBL] [Abstract][Full Text] [Related]
16. Women's interpretation of an abnormal result on measurement of fetal nuchal translucency and maternal serum screening for prenatal testing of Down syndrome.
Khoshnood B; De Vigan C; Blondel B; Lhomme A; Vodovar V; Garel M; Goffinet F
Ultrasound Obstet Gynecol; 2006 Sep; 28(3):242-8. PubMed ID: 16909402
[TBL] [Abstract][Full Text] [Related]
17. Patient and health professional acceptance of integrated serum screening for Down syndrome.
Palomaki GE; Kloza EM; Haddow JE; Williams J; Knight GJ
Semin Perinatol; 2005 Aug; 29(4):247-51. PubMed ID: 16104676
[TBL] [Abstract][Full Text] [Related]
18. Are pregnant Australian women well informed about prenatal genetic screening? A systematic investigation using the Multidimensional Measure of Informed Choice.
Rowe HJ; Fisher JR; Quinlivan JA
Aust N Z J Obstet Gynaecol; 2006 Oct; 46(5):433-9. PubMed ID: 16953859
[TBL] [Abstract][Full Text] [Related]
19. [Screening for Down syndrome using first-trimester combined screening followed by second trimester ultrasound examination in an unselected population].
Rozenberg P; Bussières L; Chevret S; Bernard JP; Malagrida L; Cuckle H; Chabry C; Durand-Zaleski I; Bidat L; Lacroix I; Moulis M; Roger M; Jacquemot MC; Bault JP; Boukobza P; Boccara P; Vialat F; Giudicelli Y; Ville Y
Gynecol Obstet Fertil; 2007 Apr; 35(4):303-11. PubMed ID: 17350315
[TBL] [Abstract][Full Text] [Related]
20. Prenatal genetic screening for Down syndrome and open neural tube defects using maternal serum markers in Thai pregnant women.
Wasant P; Liammongkolkul S
Southeast Asian J Trop Med Public Health; 2003; 34 Suppl 3():244-8. PubMed ID: 15906746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
